It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but...
ECMO Systems
Extracorporeal membrane oxygenation (ECMO) is used as a hemodymanic support system to increase the flow of blood in the body to allow the heart and lungs to rest in critically ill patients. It is similar to a heart-lung by-pass machine used in open-heart surgery. It pumps and oxygenates a patient's blood outside the body with blood flowing through tubing to an artificial lung in to add oxygen and remove carbon dioxide. The blood is then the blood is warmed to body temperature and pumped back into the patient’s body. VA ECMO is connected to both a vein and an artery when there are problems with the heart and lungs. VV ECMO is connected to one or more veins, usually near the heart, and is used when the problem in the lungs.
-
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH). Novel coronavirus has turned out to have a sizable amount of cardiovascular involvement.
-
A new, serious COVID-19 cardiovascular presentation emerged in late April and early May 2020 in the form of pediatric multi-system inflammatory syndrome, which includes features similar to...
-
May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal...
-
Justin Fried, M.D., Attending cardiologist at Columbia University Irving Medical Center, New York City, and...
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America
Feature | Coronavirus (COVID-19) | June 30, 2020
In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association with prior exposure...
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH). Novel coronavirus has turned out to have a sizable amount of cardiovascular involvement.
Feature | Coronavirus (COVID-19) | June 05, 2020 | Dave Fornell, Editor
It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger...
Rash on the skin of a child who has COVID-19 related multi-system inflammatory syndrome (MIS-C). The image is from Damien Bonnet, M.D., Ph.D., Necker Hospital-Université, Paris, who was involved in a Circulation study published on MIS-C May 14. Image copyright Damien Bonnet, courtesy of the American Heart Association.
Feature | Coronavirus (COVID-19) | May 20, 2020 | Dave Fornell, Editor
A new, serious COVID-19 cardiovascular presentation emerged in late April and early May 2020 in the form of pediatric...
The Breethe ECMO system. Abiomed invested in Breethe in mid-2019. Breethe has applied for 510(k) clearance by the Food and Drug Administration (FDA).
News | ECMO Systems | May 01, 2020
May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal...
The FDA expanded the use indications for ECMO systems April 6 so the systems can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support. Image shows an ECMO team at work at Tufts Medical Center in Boston in December 2019. Photo by Dave Fornell
News | Coronavirus (COVID-19) | April 23, 2020
April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand...
Videos | Coronavirus (COVID-19) | April 22, 2020
Justin Fried, M.D., Attending cardiologist at Columbia University Irving Medical Center, New York City, and assistant...
An ECMO cannula being inserted into a cardiovascular patient in need of mechanical oxygenation and hemodynamic support at Tufts Medical Center in December 2019. The FDA just made a temporary approval to use ECMO support in COVID-19 patients during the pandemic emergency. Photo by Dave Fornell.
Feature | Coronavirus (COVID-19) | April 07, 2020 | Dave Fornell, Editor
April 7, 2020 — The U.S. Food and Drug Administration (FDA) has issued guidance to provide a policy to help expand the...
The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.
News | Cardiovascular Surgery | February 27, 2020
February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to...
Videos | Hemodynamic Support Devices | January 24, 2020
Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of...
360 Photos | 360 View Photos | January 21, 2020
A venous-venous (VV) extracorporeal membrane oxygenation (ECMO) implantation procedure in a cath lab at Tufts Medical...
The Philips Lumify hand-held ultrasound technology is an important component of the mobile ECMO unit. Members of the ECMO team use Lumify for real-time visual guidance when inserting tubes in veins and arteries in a process called ECMO cannulation.
Feature | Ultrasound Imaging | November 26, 2019
November 26, 2019 — Physicians from the University of New Mexico (UNM) and local emergency responders recently treated...
News | Hemodynamic Support Devices | November 04, 2019
November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system error...
Videos | Hemodynamic Support Devices | September 12, 2019
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele...
Blog | Cardiovascular Surgery | February 25, 2019
Here is what I thought were the top five most important take-away presentations from the 2019 Society of Thoracic...
Two versions of the Abiomed Impella percutaneous ventricular assist device displayed at ACC 2018. Impella is the only device that currently has a FDA indication for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | July 08, 2018 | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia...
